Fecal microbiota transplant for Crohn disease: A study evaluating safety, efficacy, and microbiome profile

Emerging trials suggest fecal microbiota transplantation (FMT) is a promising treatment for ulcerative colitis; however, there is a paucity of data in Crohn disease (CD).The objectives of this article are to determine whether single-dose FMT improves clinical and endoscopic outcomes in CD patients and to identify meaningful changes in the microbiome in response to FMT.We performed a prospective, open-label, single-center study. Ten CD patients...